Penetrance & Expressivity - Genetics

1. An autosomal dominant allele 'T' causes a particular trait. The frequency of this allele in a large, randomly mating population is 0.02. If the penetrance of the allele is 75%, what is the approximate expected frequency of individuals expressing the trait in this population?
   Answer: 3.0% First, calculate the frequencies of the genotypes that can cause the trait using the Hardy-Weinberg equation. Let p = frequency of T = 0.02, and q = frequency of t = 0.98. The causative genotypes are TT and Tt. Frequency(TT) = p² = (0.02)² = 0.0004. Frequency(Tt) = 2pq = 2(0.02)(0.98) = 0.0392. Second, calculate the frequency of affected individuals by multiplying the frequency of each causative genotype by the penetrance (0.75). Affected from TT = 0.0004 0.75 = 0.0003. Affected from Tt = 0.0392 0.75 = 0.0294. The total frequency of individuals expressing the trait is the sum of these two frequencies: 0.0003 + 0.0294 = 0.0297. This is approximately 0.030, or 3.0%.
2. Which of the following scenarios best illustrates the principle of variable expressivity without clear evidence of incomplete penetrance?
   Answer: All individuals with a specific mutation for osteogenesis imperfecta have brittle bones, but some experience hundreds of fractures while others have only a few. Variable expressivity refers to the range of phenotypic severity among individuals with the same genotype. Choice B is the best example: all individuals are affected (complete penetrance), but the degree to which they are affected (number of fractures) varies greatly. Choice A and C are clear examples of incomplete penetrance. Choice D demonstrates incomplete penetrance in the parent. While the child is affected, the key distinction is that in scenario B, there is no mention of non-penetrant individuals.
3. A geneticist identifies a pathogenic variant responsible for a dominant disorder that is present in 1 out of every 200 individuals in a population. Clinical records show that the prevalence of the actual disease is 1 out of every 250 individuals. Which of the following statements is the most accurate conclusion?
   Answer: The penetrance of the variant is 80%. Penetrance is the ratio of individuals with the phenotype (disease) to individuals with the genotype (variant). The frequency of the genotype is 1/200. The frequency of the phenotype is 1/250. Penetrance = (Frequency of Phenotype) / (Frequency of Genotype) = (1/250) / (1/200) = 200/250 = 0.80, or 80%. Choice A is a nonsensical value for penetrance. Choice B misuses the term expressivity, which refers to the range of symptoms, not a calculated percentage in this context. Choice D is contradicted by the data (1/200 > 1/250).
4. An individual heterozygous for an autosomal dominant allele that causes Polydactyly partners with an individual who is homozygous recessive. The condition has 90% penetrance. What is the probability that their first child will be phenotypically unaffected?
   Answer: 55% A child can be phenotypically unaffected in two ways: 1) they do not inherit the dominant allele, or 2) they inherit the dominant allele but do not express the trait (non-penetrance). Let 'A' be the dominant allele and 'a' be the recessive allele. The cross is Aa × aa. The probability of the child inheriting the 'a' allele from the heterozygous parent is 1/2, resulting in genotype aa and an unaffected phenotype. P(aa) = 0.5. The probability of the child inheriting the 'A' allele is 1/2. If the child has the 'A' allele (genotype Aa), the penetrance is 90%, so the probability of being non-penetrant (unaffected) is 1 - 0.90 = 0.10. The probability of this combined event is P(Aa) × P(unaffected|Aa) = 0.5 × 0.10 = 0.05. The total probability of being unaffected is the sum of the probabilities of these two mutually exclusive events: P(unaffected) = P(aa) + P(unaffected and Aa) = 0.5 + 0.05 = 0.55, or 55%.
5. An individual who is heterozygous (Aa) for a dominant allele causing a disorder with 80% penetrance has a child with an individual who is homozygous recessive (aa). What is the probability that their child will be a phenotypically normal carrier of the disease allele?
   Answer: 10% This question asks for the probability of a specific combined outcome: the child must have the causative genotype AND be phenotypically normal. First, the probability that the child inherits the disease allele 'A' from the heterozygous parent is 1/2 or 50%. This means the child's genotype is Aa. Second, given the child has the Aa genotype, the probability of expressing the phenotype is the penetrance, 80%. The probability of not expressing the phenotype (being a non-penetrant carrier) is 1 - penetrance = 1 - 0.80 = 0.20 or 20%. The total probability of being a phenotypically normal carrier is the product of these two probabilities: P(inheriting 'A') × P(non-penetrance | has 'A') = 0.50 × 0.20 = 0.10, or 10%.
6. A 30-year-old man tests positive for a pathogenic variant in the BRCA1 gene. This specific variant is inherited in an autosomal dominant manner and has an estimated lifetime penetrance of 60% for breast cancer in males. Which of the following is the most accurate counseling statement regarding his personal risk for developing breast cancer?
   Answer: He has a 60% chance of developing breast cancer in his lifetime due to this specific genetic variant. Penetrance is the probability that an individual with the causative genotype will express the phenotype. Since the man has already tested positive for the variant, his chance of having the genotype is 100%. Therefore, his lifetime risk of developing the associated cancer is equal to the penetrance, which is 60%. Choice A is incorrect because 40% of carriers will not develop the cancer (incomplete penetrance). Choice B is incorrect because he already has the variant; the 50% inheritance probability is no longer relevant for him. Choice C incorrectly applies the penetrance value to his children's risk of disease instead of their risk of inheritance (which is 50%).
7. A new autosomal dominant syndrome is characterized by two main features: vision loss and hearing impairment. A study of 500 individuals, all heterozygous for the same causative mutation, reveals the following: 100 individuals remain completely asymptomatic; 250 develop only vision loss; 50 develop only hearing impairment; and 100 develop both vision and hearing loss. What is the penetrance of this syndrome?
   Answer: 80% Penetrance is the proportion of individuals with a given genotype who exhibit any part of the associated phenotype. The total number of individuals with the mutation is 500. The number of asymptomatic individuals is 100. Therefore, the number of symptomatic (affected) individuals is 500 - 100 = 400. The penetrance is the number of affected individuals divided by the total number of carriers: 400 / 500 = 0.80, or 80%. The different combinations of symptoms (vision only, hearing only, both) are an example of variable expressivity but do not change the overall calculation of penetrance.
8. A specific mutation in the CFTR gene causes cystic fibrosis, leading to a spectrum of health issues including chronic lung infections, pancreatic insufficiency, and male infertility. While essentially all individuals with this genotype develop some health problems, the severity of the lung disease can range from mild to life-threatening. Which pair of genetic concepts correctly describes the multiple organ systems affected and the differing severity of lung disease, respectively?
   Answer: Pleiotropy and variable expressivity The fact that a single gene mutation (in CFTR) affects multiple, distinct organ systems (lungs, pancreas, reproductive tract) is the definition of pleiotropy. The observation that the severity of the lung disease varies among individuals with the same genotype is the definition of variable expressivity. The stem says "essentially all individuals...develop some health problems," which points to complete or near-complete penetrance, making choices with incomplete penetrance less likely. Polygenic inheritance refers to a trait controlled by multiple genes, which is not the case here.
9. Marfan syndrome results from mutations in the FBN1 gene and is inherited as an autosomal dominant trait. Affected individuals can have a wide range of clinical features, including being unusually tall, having long limbs and fingers (arachnodactyly), and developing severe cardiovascular problems like aortic aneurysms. The severity and combination of these features differ significantly among patients, even within the same family sharing the identical FBN1 mutation. Which genetic concept is best illustrated by this variation in the type and severity of symptoms among affected individuals?
   Answer: Variable expressivity The question focuses on the variation in the severity and combination of symptoms among individuals who share the same causative mutation. This phenomenon, where a single genotype produces a range of phenotypic expressions, is defined as variable expressivity. Incomplete penetrance refers to individuals with the genotype who show no phenotype, which is not the focus here. Allelic heterogeneity refers to different mutations in the same gene causing the condition, while locus heterogeneity refers to mutations in different genes causing a similar condition; neither describes variation among those with the identical mutation.
10. Two different families present with members affected by hypercholesterolemia. In Family 1, all affected individuals have a deletion of exon 4 in the LDLR gene and exhibit moderate to severe symptoms. In Family 2, all affected members have a missense mutation in exon 10 of the same LDLR gene and consistently present with a very mild form of the condition. The difference in clinical presentation between these two families is best described as an example of:
    Answer: Allelic heterogeneity The scenario describes two different mutations (alleles) within the same gene (LDLR) that lead to clinically distinct forms of the same disease (hypercholesterolemia). This phenomenon is known as allelic heterogeneity. Variable expressivity is a plausible distractor, but it refers to the variation in phenotype among individuals sharing the same allele, which is not what is being compared here. Locus heterogeneity would involve mutations in different genes causing the condition. Incomplete penetrance is not mentioned in the scenario.
11. Based on the passage, which concepts best explain the clinical observations associated with NF1?
    Answer: Incomplete penetrance and variable expressivity The passage describes two key phenomena. The fact that individuals with the same pathogenic allele can show a wide range of symptoms, from very mild (a few spots) to severe (hundreds of tumors), is a classic example of variable expressivity. The fact that a small percentage of individuals with the allele show no clinical symptoms at all is the definition of incomplete penetrance. Therefore, both concepts are required to fully explain the observations.
12. A dominant allele 'G' is associated with a specific phenotype. In a survey of 1,000 individuals, genetic testing reveals 150 individuals with genotype Gg and 10 with genotype GG. Phenotypic assessment finds that 96 individuals in the total sample exhibit the trait. Assuming the penetrance is the same for both Gg and GG genotypes, what is the penetrance of the 'G' allele in this population?
    Answer: 60.0% Penetrance is the proportion of individuals with a causative genotype who exhibit the corresponding phenotype. First, determine the total number of individuals with the causative genotype. This is the sum of individuals with Gg and GG genotypes: 150 + 10 = 160 individuals. The problem states that 96 of these individuals exhibit the phenotype. Penetrance is calculated as (Number of affected individuals) / (Total number of individuals with the causative genotype). Therefore, Penetrance = 96 / 160 = 0.60, or 60.0%.
13. A specific mutation in gene A causes an autosomal dominant cardiac condition with a baseline penetrance of 70%. Researchers discover that all non-penetrant individuals carrying the gene A mutation are also homozygous for a recessive allele 'b' at a second, unlinked gene B. Individuals with at least one dominant 'B' allele show the full baseline penetrance. Given this information, what is the penetrance of the cardiac condition in an individual with the specific genotype AaBb?
    Answer: 70% The question describes a modifier gene effect. The presence of at least one dominant 'B' allele is required for the phenotype from gene A to manifest. The problem states that individuals with at least one 'B' allele exhibit the 'full baseline penetrance' of 70%. The individual in question has the genotype AaBb. They have the disease-causing allele 'A' and the permissive modifier allele 'B'. Therefore, their probability of being affected is simply the baseline penetrance given for this genetic background, which is 70%. The other probabilities are distractors based on misinterpretations, such as multiplying by inheritance probabilities that are not relevant when the genotype is already known.
14. A researcher studies a very rare, late-onset autosomal dominant disease. A review of pedigrees consistently shows that the disease appears in every generation of affected families, with males and females being affected equally. However, when large families are analyzed, approximately 15% of individuals who must be carriers (based on their parentage and offspring) never develop symptoms. Among those who do develop symptoms, the age of onset can vary by decades. This disease is best characterized as having:
    Answer: Incomplete penetrance and variable expressivity. The observation that approximately 15% of obligate carriers remain asymptomatic demonstrates incomplete penetrance (specifically, 100% - 15% = 85% penetrance). The fact that the age of onset (a key feature of the phenotype) varies significantly among affected individuals is a clear example of variable expressivity. The other information (appearing in every generation, affecting males and females equally) confirms the autosomal dominant inheritance pattern but does not describe the nuances of its expression.
15. A rare autosomal dominant neurological disorder is studied. In a large population at Hardy-Weinberg equilibrium, the frequency of the disease-causing allele (A) is 0.001. A survey finds the prevalence of the disorder (the proportion of affected individuals) to be 1 in 1,250. Assuming all affected individuals are heterozygotes due to the rarity of the allele, what is the penetrance of the A allele?
    Answer: 40% First, calculate the expected frequency of the heterozygous genotype (Aa) in the population using the Hardy-Weinberg equation. The frequency of the allele A (p) is 0.001, so the frequency of the allele a (q) is 1 - 0.001 = 0.999. The frequency of heterozygotes is 2pq = 2 0.001 0.999 ≈ 0.002. This is equivalent to 1 in 500 individuals (1/0.002). The observed prevalence of the phenotype is 1 in 1,250. Penetrance is the ratio of the observed phenotype frequency to the causative genotype frequency. Penetrance = (Phenotype Frequency) / (Genotype Frequency) = (1/1,250) / (1/500) = 500 / 1,250 = 0.40, or 40%.
16. A 25-year-old woman's father was recently diagnosed with Huntington's disease, an autosomal dominant disorder with age-dependent penetrance. The penetrance is near 0% at age 25, rises to 50% by age 40, and approaches 100% by age 65. The woman is currently asymptomatic. Which statement is the most accurate assessment of her situation?
    Answer: Her risk of having inherited the allele is 50%, and her lack of symptoms at this age provides very little information about her carrier status. As the child of an affected individual, her prior risk of inheriting the autosomal dominant allele is 50%. Because the penetrance of Huntington's disease is near zero at her current age of 25, being asymptomatic is expected whether she carries the allele or not. Therefore, her current health status does little to change the initial 50% probability that she is a carrier. Choice A is incorrect because being symptom-free at an age where symptoms are not expected does not significantly reduce her genetic risk. Choice B is incorrect; her overall risk of being symptomatic by 40 is 0.5 (chance to inherit) × 0.5 (penetrance at 40) = 25%. Choice D is a common error; the child's risk is 50% only if she is a carrier. Her overall risk of passing it on is 25% (0.5 chance she has it * 0.5 chance she passes it on).
17. Malignant hyperthermia is an autosomal dominant condition where affected individuals experience a life-threatening reaction to certain anesthetic drugs. Individuals with a pathogenic RYR1 mutation are phenotypically normal in their daily lives and only develop symptoms upon exposure to a specific trigger. This inheritance pattern is best described as an example of:
    Answer: Penetrance dependent on a specific environmental factor This is a classic example of gene-environment interaction within a Mendelian disorder. The penetrance is incomplete because having the pathogenic genotype is not, by itself, sufficient to cause the phenotype. An external, environmental trigger (the anesthetic drug) is required. Therefore, the penetrance is conditional or dependent on this specific factor. It is not complete penetrance, as carriers are normal without the trigger. It is not primarily age-dependent, but trigger-dependent. While it involves an environmental factor, the clear autosomal dominant inheritance pattern makes it a Mendelian trait with an environmental dependency, not a complex multifactorial trait.
18. The graph shows the clinical findings in a cohort of patients with the same pathogenic mutation for von Hippel-Lindau (VHL) disease. Which genetic principles are best illustrated by these data?
    Answer: Incomplete penetrance and variable expressivity The graph illustrates two key principles. The bar for '0' retinal angiomas shows that 15% of individuals with the pathogenic mutation do not express this particular phenotype, which is an example of incomplete penetrance. Among the 85% of individuals who do express the phenotype, the number of angiomas varies widely (from 1 to 7+). This variation in the degree of phenotypic expression among affected individuals is a classic example of variable expressivity. Therefore, the data demonstrate both concepts.
19. A pedigree is analyzed for a rare genetic disorder. Individual II-2 is phenotypically normal, as is his partner, II-3. However, they have an affected child, III-1. Individual II-2's father, I-1, was affected by the same disorder. The disorder is known to be autosomal dominant with 70% penetrance. What is the probability that the next child of II-2 and II-3 will be affected by the disorder?
    Answer: 35.00% The mode of inheritance is autosomal dominant. Individual II-2 is an obligate carrier of the disease allele because he is unaffected but has both an affected father (I-1) and an affected child (III-1). He must have inherited the allele from his father and passed it to his child, but did not express the trait due to incomplete penetrance. Therefore, II-2's genotype is heterozygous (e.g., Aa). His partner, II-3, is unaffected and, as the trait is rare, is assumed to be homozygous recessive (aa). The probability that their next child will inherit the dominant allele 'A' from II-2 is 1/2. The probability that an individual with the allele will express the phenotype is the penetrance, which is 70% (or 0.7). Therefore, the overall probability of the next child being affected is P(inherit allele) × P(express phenotype) = 0.5 × 0.7 = 0.35, or 35.0%.
20. Split-hand/foot malformation (SHFM) is a condition that can be inherited as an autosomal dominant trait. In an extensive study of a family with a single causative mutation, 100 individuals are determined to be carriers of the mutation. Of these, 70 show some form of SHFM, while 30 have completely normal hands and feet. Of the 70 affected individuals, 20 have malformations of all four limbs, while 50 have malformations affecting only one or two limbs. Which statement accurately quantifies a genetic principle in this family?
    Answer: The penetrance is 70% and the condition shows variable expressivity. Penetrance is the percentage of carriers who show the phenotype. Here, 70 out of 100 carriers are affected, so the penetrance is 70/100 = 70%. Expressivity describes the range of symptoms in affected individuals. Since affected individuals can have one, two, or all four limbs affected, the condition shows variable expressivity. Choice A confuses the terms. Choice B has the incorrect penetrance value (30% is the rate of non-penetrance). Choice D is incorrect because expressivity is variable, not uniform, among those who are penetrant.

Start this quiz